There was much discussion about current research in FAODs at our recent International Metabolic conference last month. Reneo Pharmaceuticals recently released positive results from the REN001 Phase1b LC-FAOD Study.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
